Top pharmaceutical R&D projects based on net present value May 2019

This statistic depicts the most valuable research and development projects in the pharmaceutical industry worldwide as of May 2019, based on net present value in million U.S. dollars. AbbVie's Upadacitinib project claimed a net present value of 10.25 billion U.S. dollars as of May 2019.

Selected top pharmaceutical R&D projects based on net present value (NPV) as of May 2019

Product (Company)Net present value in million U.S. dollars
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

June 2019

Region

Worldwide

Survey time period

as of May 2019

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical market worldwide"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.